OTC, PLCKF #Upcoming Presentation Plurilock to Present at 2023 World Outlook Financial Conference January 30, 2023 07:00 EST Since 1990, the goal at the World Outlook Financial Conference is to protect individual investors financially, help them thrive by understanding the major trends, and introduce them to quality investment opportunities. Vancouver, British Columbia–(Newsfile Corp. – January 30, 2023) – Plurilock Security Inc. (TSXV: PLUR) (OTCQB: PLCKF) and related No Comments
NASDAQ, OPT #Upcoming Presentation Opthea To Present at Sequire Biotechnology Conference January 30, 2023 06:00 EST MELBOURNE, Australia, Jan. 30, 2023 (GLOBE NEWSWIRE) — Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that Dr. Megan Baldwin, the Company’s Chief Executive Officer will present at the Sequire Biotechnology Conference being held virtually No Comments
GALKF, OTC #Upcoming Presentation Galantas Gold to Present on Geology and District-Scale Potential of the Gairloch Project in a Webcast on February 1, 2023 January 30, 2023 02:00 EST TORONTO, Jan. 30, 2023 (GLOBE NEWSWIRE) — Galantas Gold Corporation (TSX-V & AIM: GAL; OTCQX: GALKF) (“Galantas” or the “Company”) will be hosting a live webcast on February 1, 2023, 11:00am Eastern Time, to discuss the Gairloch Project, a 217 km² mineral licence area in Scotland that covers the No Comments
BICX, OTC #Upcoming Presentation BioCorRx to Present at Sequire Biotechnology Conference on February 2nd January 27, 2023 08:30 EST Presentation on Thursday, February 2, 2023 at 2:00 PM ET ANAHEIM, CA, Jan. 27, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance use and related disorders, announced today that Lourdes Felix, Chief Executive Officer, Chief Financial Officer, No Comments
AMRN, NASDAQ #Cardiovascular #Trending News #Upcoming Presentation Amarin to Present at SVB Securities Global Biopharma Conference January 27, 2023 08:00 EST DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 27, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today announced that Karim Mikhail, Amarin’s president and chief executive officer, is scheduled to participate at the SVB Securities Global Biopharma Conference. SVB Securities Global Biopharma Conference (February 13-16th, 2023; Virtual) Date/Time: February 14, No Comments
NASDAQ, WLDS, WLDSW #New Order #Trending News #Upcoming Presentation Wearable Devices Selected to Present at Best of CES 2023 January 27, 2023 07:00 EST The company was invited to present at the event highlighting trends and products from CES 2023 at The Paley Center for Media in New York City YOKNEAM ILLIT, ISRAEL, Jan. 27, 2023 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (“Wearable Devices”), a growth company developing a non-invasive No Comments
ARTL, NASDAQ #Cancer #Upcoming Presentation Artelo Biosciences to Present at Sequire Biotechnology Conference on February 2nd January 26, 2023 08:30 EST CEO Gregory Gorgas to discuss developments related to the Company’s Cancer Appetite Recovery Study (CAReS) Presentation on Thursday, February 2, 2023 at 1:00 PM ET SOLANA BEACH, Calif., Jan. 26, 2023 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for No Comments
NASDAQ, OSA #Upcoming Presentation ProSomnus® Announces Acceptance of Abstract for Oral Presentation at Prestigious American Thoracic Society 2023 International Conference January 26, 2023 08:00 EST SAN FRANCISCO, Jan. 26, 2023 (GLOBE NEWSWIRE) — ProSomnus, Inc. (“the Company”) (NASDAQ: OSA), a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced that an abstract showcasing data from the First Line Obstructive Sleep Apnea Treatment study (FLOSAT) has been accepted for No Comments
LOOP, NASDAQ #Trending News #Upcoming Presentation Loop Industries to Present at the 30th Annual Emerald Groundhog Day Investment Forum on February 2nd, 2023 January 25, 2023 16:10 EST MONTREAL, QC / ACCESSWIRE / January 25, 2023 / Loop Industries, Inc. (NASDAQ:LOOP) (the “Company” or “Loop”), a clean technology company whose mission is to accelerate a circular plastics economy by manufacturing 100% recycled polyethylene terephthalate (“PET”) plastic and polyester fiber, today announced that Kevin O’Dowd, Vice President of No Comments
OGOFF, OTC #Upcoming Presentation Organto Announces 2023 Business Outlook Webinar January 25, 2023 08:59 EST January 30, 2023, at 4:15 PM EST VANCOUVER, BC and BREDA, the NETHERLANDS / ACCESSWIRE / January 25, 2023 / Organto Foods Inc. (TSXV:OGO)(OTCQB:OGOFF)(FSE:OGF) (Organto), a leading provider of organic and non-GMO value-added fruit and vegetable products, today announced that it will host a 2023 Business Outlook Webinar on No Comments
Flora Growth Issues 2023 Revenue Guidance of $90 Million to $105 Million Reflecting Anticipated Year Over Year Growth Exceeding 100% 01/30/2023
Kuke Music Launches Advanced Digital Teaching System in Collaboration with People’s Music Publishing House 01/30/2023
STEER Announces a Proposed Transaction for an $18 Million Direct Investment Involving its Digital Restaurant Supply Business (B2B Marketplace) 01/23/2023
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Silvergate Capital Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – SI 01/23/2023